Pharmalicensing.com: Industry news http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us Pharmalicensing.com: Industry news http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 IMS Health Reports Global Biotech Sales Grew 12.5 Percent in 2007, Exceeding $75 Billion NORWALK, CT, June 17, 2008 -- Global prescription sales of biotech drugs increased 12.5 percent in 2007 to more than $75 billion, according to a new report by IMS Health (NYSE: RX), the world's... http://pharmalicensing.com/redirs/news_rss//public/news/view/426894/3 http://pharmalicensing.com/redirs/news_rss//public/news/view/426894/3 KV Pharmaceutical Company Reports Fiscal 2008 Results St. Louis, MO, June 16, 2008 - KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology... http://pharmalicensing.com/redirs/news_rss//public/news/view/426571/3 http://pharmalicensing.com/redirs/news_rss//public/news/view/426571/3 Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2008 KAILUA KONA, Hawaii (June 26, 2008) -- Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing high-value nutrition and health products from microalgae, today announced... http://pharmalicensing.com/redirs/news_rss//public/news/view/428848/3 http://pharmalicensing.com/redirs/news_rss//public/news/view/428848/3 POLYDEX REPORTS FIRST QUARTER FINANCIAL RESULTS SHAREHOLDER EQUITY OF COMPANY EXCEEDS CURRENT SHARE PRICE Toronto, Ontario, June 13, 2008 -- Polydex Pharmaceuticals Limited (NASDAQ:POLXF) has today reported financial results of operations for the first quarter of fiscal 2009, ending April 30, 2008. http://pharmalicensing.com/redirs/news_rss//public/news/view/426582/3 http://pharmalicensing.com/redirs/news_rss//public/news/view/426582/3 Interim results for the six months ended 31 March 2008 June 26, 2008-- Keele, UK: Cobra Biomanufacturing Plc (AIM: CBF), the international manufacturer of biopharmaceuticals, today announces its interim results for the six months ended 31 March 2008. http://pharmalicensing.com/redirs/news_rss//public/news/view/428863/3 http://pharmalicensing.com/redirs/news_rss//public/news/view/428863/3